InsiderTrades

Kong Garheng

SEC CIK 1435183 · EDGAR

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
XERSXeris Biopharma Holdings, Inc.Dir 238.3K — — 82021-10-052026-06-04
LHLabcorpDir 13.7K — — 52022-02-022026-02-11

Most active insiders at XERS, 12 months

#InsiderTitleBoughtSold
1 Hecht BethSee Remarks —$1.31M
2 McCulloch KevinSee Remarks —$1.09M
3 JOHNSON JOHNDir —$1.07M
4 Pieper StevenSee Remarks —$468.2K
5 Shannon John Patrick JrSee Remarks, Dir —$349.7K
6 BORMANN-KENNEDY BARBARA-JEAN ANNEDir —$203.9K
7 HALKUFF DAWNDir —$121.9K
8 PERSKY MARLADir —$91.4K
9 Brady James AloysiusDir —$60.0K
10 Nguyen Anh TuSee Remarks ——
12 Kong GarhengDir ——

Transactions 13

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
D 2026-06-05 18:39 2026-06-04 XERS Xeris Biopharma Holdings, Inc. Kong Garheng Dir A - Grant $0.00 +24.2K 238.3K +11% $0
D 2026-02-13 2026-02-11 LH Labcorp Kong Garheng Dir M - OptEx — +897 13.7K +7% —
2025-06-04 2025-06-04 XERS Xeris Biopharma Holdings, Inc. Kong Garheng Dir A - Grant $0.00 +50.0K 214.1K +30% $0
D 2025-02-10 2025-02-06 LH Labcorp Kong Garheng Dir M - OptEx — +944 12.8K +8% —
2024-06-05 2024-06-05 XERS Xeris Biopharma Holdings, Inc. Kong Garheng Dir A - Grant $0.00 +50.0K 164.1K +44% $0
2024-04-01 2024-03-15 XERS Xeris Biopharma Holdings, Inc. Kong Garheng Dir J - Other — +6,474 114.1K +6% —
D 2024-02-08 2024-02-07 LH Labcorp Kong Garheng Dir M - OptEx — +947 11.9K +9% —
2023-06-07 2023-06-07 XERS Xeris Biopharma Holdings, Inc. Kong Garheng Dir A - Grant $0.00 +42.5K 107.7K +65% $0
D 2023-02-14 2023-02-11 LH Labcorp Kong Garheng Dir M - OptEx — +742 11.0K +7% —
D 2022-06-09 2022-06-08 XERS Xeris Biopharma Holdings, Inc. Kong Garheng Dir A - Grant $0.00 +15.0K 65.2K +30% $0
D 2022-02-04 2022-02-02 LH Labcorp Kong Garheng Dir M - OptEx — +771 10.2K +8% —
DA 2021-10-08 2021-10-05 XERS Xeris Biopharma Holdings, Inc. Kong Garheng Dir A - Grant — +50.2K 50.2K New —
D 2021-10-05 2021-10-05 XERS Xeris Biopharma Holdings, Inc. Kong Garheng Dir A - Grant — +50.2K 50.2K New —

Purchase Sale Sale after option exercise All abbreviations